These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17447509)

  • 1. Early recurrence of completely resected N2-positive non-small-cell lung cancer.
    Tsukioka T; Nishiyama N; Iwata T; Izumi N; Mizuguchi S; Morita R; Inoue K; Suehiro S
    Gen Thorac Cardiovasc Surg; 2007 Mar; 55(3):113-8. PubMed ID: 17447509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of subcarinal station in non-small cell lung cancer with T1-3 N2 disease.
    Iwasaki A; Shirakusa T; Miyoshi T; Hamada T; Enatsu S; Maekawa S; Hiratsuka M
    Thorac Cardiovasc Surg; 2006 Feb; 54(1):42-6. PubMed ID: 16485188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overall survival and local recurrence of 406 completely resected stage IIIa-N2 non-small cell lung cancer patients: questionnaire survey of the Japan Clinical Oncology Group to plan for clinical trials.
    Ichinose Y; Kato H; Koike T; Tsuchiya R; Fujisawa T; Shimizu N; Watanabe Y; Mitsudomi T; Yoshimura M;
    Lung Cancer; 2001 Oct; 34(1):29-36. PubMed ID: 11557110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for local recurrence after lobectomy and lymph node dissection in patients with non-small cell lung cancer: Implications for adjuvant therapy.
    Isaka M; Kojima H; Takahashi S; Omae K; Ohde Y
    Lung Cancer; 2018 Jan; 115():28-33. PubMed ID: 29290258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Completely resected N1 non-small cell lung cancer: factors affecting recurrence and long-term survival.
    Fujimoto T; Cassivi SD; Yang P; Barnes SA; Nichols FC; Deschamps C; Allen MS; Pairolero PC
    J Thorac Cardiovasc Surg; 2006 Sep; 132(3):499-506. PubMed ID: 16935101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic factors of resected non-small cell lung cancer with chest wall invasion.
    Lee CY; Byun CS; Lee JG; Kim DJ; Cho BC; Chung KY; Park IK
    World J Surg Oncol; 2012 Jan; 10():9. PubMed ID: 22236955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Factors influencing survival and recurrence and potential significance of postoperative radiotherapy and adjuvant chemotherapy for stage ⅢA-N2 non-small cell lung cancer].
    Han W; Song YZ; He M; Li J; Zhang R; Qiao XY
    Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):861-867. PubMed ID: 27998447
    [No Abstract]   [Full Text] [Related]  

  • 8. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
    Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
    Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of Muscle Mass is a Novel Predictor of Postoperative Early Recurrence in N2-Positive Non-Small-Cell Lung Cancer.
    Tsukioka T; Izumi N; Kyukwang C; Komatsu H; Toda M; Hara K; Nishiyama N
    Ann Thorac Cardiovasc Surg; 2018 Jun; 24(3):121-126. PubMed ID: 29459570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of subsets of patients with favorable prognosis after recurrence in completely resected non-small cell lung cancer.
    Sonobe M; Yamada T; Sato M; Menju T; Aoyama A; Sato T; Chen F; Omasa M; Bando T; Date H
    Ann Surg Oncol; 2014 Aug; 21(8):2546-54. PubMed ID: 24633668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting long-term survival after en-bloc resection of lung cancer invading the chest wall.
    Chapelier A; Fadel E; Macchiarini P; Lenot B; Le Roy Ladurie F; Cerrina J; Dartevelle P
    Eur J Cardiothorac Surg; 2000 Nov; 18(5):513-8. PubMed ID: 11053809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative radiotherapy in radically resected non-small cell lung cancer.
    Mayer R; Smolle-Juettner FM; Szolar D; Stuecklschweiger GF; Quehenberger F; Friehs G; Hackl A
    Chest; 1997 Oct; 112(4):954-9. PubMed ID: 9377958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved.
    Matsuguma H; Nakahara R; Ishikawa Y; Suzuki H; Inoue K; Katano S; Yokoi K
    Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):573-7. PubMed ID: 18413349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer.
    Feng W; Li Y; Shen L; Cai XW; Zhu ZF; Chang JH; Xiang JQ; Zhang YW; Chen HQ; Fu XL
    Oncotarget; 2016 Feb; 7(6):7227-40. PubMed ID: 26811495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic nodal dissection in the intrathoracic staging of patients with non-small cell lung cancer.
    Graham AN; Chan KJ; Pastorino U; Goldstraw P
    J Thorac Cardiovasc Surg; 1999 Feb; 117(2):246-51. PubMed ID: 9918964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
    Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
    Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
    Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
    Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor Size and N2 Lymph Node Metastasis Are Significant Risk Factors for Early Recurrence in Completely Resected Centrally Located Primary Lung Cancer Patients.
    Tsukioka T; Izumi N; Komatsu H; Inoue H; Miyamoto H; Ito R; Kimura T; Nishiyama N
    Anticancer Res; 2021 Apr; 41(4):2165-2169. PubMed ID: 33813428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Patients Unable to Undergo Adjuvant Chemotherapy after Surgery in Stage IIIA/B Non-Small Cell Lung Cancer: Will They Benefit from Mediastinal Radiotherapy?
    Graeter TP; Sebastian B; Bischof M; Kugler G; Fischer JR; Schneider T
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):501-6. PubMed ID: 26322832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.